07 August 2017
Visiongain has launched a new pharma report Smart Pill Market World Market Forecast 2017-2027: See Prospects for Capsule Endoscopy, Drug Delivery and Patient Monitoring in North America, South America, Europe, Asia-Pacific and the Rest of the World
Smart Pill technology is a revolutionary technological innovation that has bridged the gap between healthcare and digital technology. Smart Pills are basically medical devices and small embedded electronic appliances such as sensors, cameras and trackers. This electronic device can be easily swallowed and it also provides complete evaluation of the gastrointestinal tract (GIT).
The emergence of these ‘healthcare-cum-technology’ devices has addressed the soaring need for better diagnostics and monitoring. It has outperformed the conventional GI monitoring endoscopy with more convenient Smart Pill technology, which has now become the standard non-invasive diagnosis technique for motility disorders. Moreover, it helps physicians in real-time patient monitoring through remote controlling options.
The lead Visiongain report analyst for this report commented; “The Value Chain of the Smart Pill technology market includes different stakeholders such as Raw material suppliers, Manufacturers, Suppliers/distributers, Service providers, and Payers (Hospitals and clinics). Each stakeholder plays a different role and the activities indicate the direct influence that production processes have on the Smart Pill technology market. The functioning of primary activities is supplemented by supporting activities without any disruption in the production process. These support activities in the Smart Pill technology include technological advancements, patent protection, research and development activities along with government regulations and reimbursement. Primary and secondary activities are greatly influenced by external stakeholders such as suppliers, end-users and payers (Hospitals and clinics).
However, clinicians, doctors and gastroenterologist sometimes prefer traditional endoscopy procedures due to its comparatively lower cost than capsule endoscopy systems. Moreover, in under developed regions like Africa, doctors for the sake of patient’s affordability mostly prefer traditional endoscopy techniques. However, the diagnostic results offered by the capsule endoscopy technique is far better than traditional endoscopy techniques, thus, the smart pill market is expected to increase significantly in size over the forecast period”
The Smart Pill Market World Market Forecast market is highly competitive with many different players entering the market. The report discusses selected leading companies in the market. Notable companies in the global smart pill market Cerner Corporation,
GE Healthcare, Proteus Digital Health Inc, Boston Scientific Corporation, Capso Vision Inc., Fujifilm Holdings Corporation, Medtronic PLC, Bio-Image Drug Delivery Limited (BDD), Hoya Corporation (PENTAX Medical) and Olympus Corporation.
Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to firstname.lastname@example.org or call her on +44 (0) 207 336 6100
Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.
Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.
Increasing demand for medical products in developing as well developed economies coupled with rising ageing population is expected to open new opportunities for medical device contract manufacturing industry over the forecast period.
01 December 2020
With the growing burden of rare diseases around the world, there has been a rise in the requirement for proper diagnosis as well as full proof treatment positions for various chronic diseases. With increasing awareness regarding symptoms of various terminal illnesses, the diagnosis rates have been improving in developing countries such as China, India, Japan, Brazil, and other southeast Asian countries.
01 December 2020
Rising preference for personalised medicine in developed as well developing economies coupled with increasing investment by biotechnological and pharmaceutical companies for drug discovery is expected to increase RNA analysis/transcriptomics market concentration over the forecast period. In order to increase the reliability and success rate of the drug production process.
30 November 2020
The market is forecasted for the next ten years based on market growth within each segment of the blood plasma products. The report study aims to explore the market drivers, restraints and also market opportunities facing blood plasma product stakeholders in different geographic areas.